LENTI, MARCO VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 7.861
AS - Asia 5.443
EU - Europa 4.716
SA - Sud America 813
Continente sconosciuto - Info sul continente non disponibili 422
AF - Africa 285
OC - Oceania 14
Totale 19.554
Nazione #
US - Stati Uniti d'America 7.593
CN - Cina 1.787
SG - Singapore 1.425
IE - Irlanda 987
IT - Italia 951
HK - Hong Kong 744
RU - Federazione Russa 692
DE - Germania 662
BR - Brasile 591
VN - Vietnam 586
FI - Finlandia 437
FR - Francia 290
IN - India 232
BD - Bangladesh 186
GB - Regno Unito 163
ZA - Sudafrica 153
CA - Canada 137
NL - Olanda 77
AR - Argentina 70
MX - Messico 70
IQ - Iraq 67
PL - Polonia 67
JP - Giappone 66
SE - Svezia 63
ES - Italia 49
TR - Turchia 45
UA - Ucraina 44
EC - Ecuador 41
AT - Austria 40
ID - Indonesia 38
MA - Marocco 36
PK - Pakistan 36
BE - Belgio 33
CO - Colombia 29
CZ - Repubblica Ceca 28
RO - Romania 25
SA - Arabia Saudita 24
PH - Filippine 22
CL - Cile 21
UZ - Uzbekistan 20
LT - Lituania 19
TN - Tunisia 19
VE - Venezuela 19
IL - Israele 18
JO - Giordania 17
AE - Emirati Arabi Uniti 16
EG - Egitto 15
PY - Paraguay 15
MY - Malesia 14
PE - Perù 13
AU - Australia 12
CH - Svizzera 12
CR - Costa Rica 12
DZ - Algeria 11
JM - Giamaica 11
KG - Kirghizistan 10
KE - Kenya 9
OM - Oman 9
GR - Grecia 8
TH - Thailandia 8
AZ - Azerbaigian 7
CM - Camerun 7
MD - Moldavia 7
RS - Serbia 7
UY - Uruguay 7
BO - Bolivia 6
IR - Iran 6
LV - Lettonia 6
PT - Portogallo 6
BY - Bielorussia 5
ET - Etiopia 5
HN - Honduras 5
KZ - Kazakistan 5
MK - Macedonia 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
GE - Georgia 4
HR - Croazia 4
HU - Ungheria 4
KH - Cambogia 4
KR - Corea 4
KW - Kuwait 4
LB - Libano 4
SI - Slovenia 4
TJ - Tagikistan 4
TW - Taiwan 4
AL - Albania 3
BH - Bahrain 3
DM - Dominica 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GA - Gabon 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
NP - Nepal 3
QA - Qatar 3
SV - El Salvador 3
ZW - Zimbabwe 3
Totale 19.073
Città #
San Jose 1.143
Dublin 983
Dallas 868
Ashburn 838
Singapore 803
Hong Kong 722
Chandler 685
Beijing 461
Munich 403
Los Angeles 273
Helsinki 272
New York 206
Ho Chi Minh City 204
Milan 204
Boardman 200
Lauterbourg 195
Nanjing 162
Shanghai 149
Moscow 141
Johannesburg 139
Princeton 134
Lawrence 132
Medford 131
Turku 128
Hanoi 124
Redondo Beach 122
Council Bluffs 114
Wilmington 87
Buffalo 82
Santa Clara 82
Pavia 81
Jacksonville 76
Orem 68
São Paulo 68
Pune 62
Nanchang 61
Tokyo 61
Warsaw 60
Shenyang 59
Hebei 58
Ann Arbor 49
Chennai 49
Rome 45
Changsha 44
Frankfurt am Main 44
Nuremberg 44
Chicago 42
Da Nang 41
Montreal 41
Jiaxing 40
Toronto 39
Denver 37
Brooklyn 36
Dearborn 36
London 35
Tianjin 34
Brussels 33
Haiphong 33
Houston 33
Guangzhou 32
San Francisco 32
Atlanta 30
Hangzhou 30
Boston 29
Amsterdam 28
Mexico City 26
Paris 25
Seattle 25
Stockholm 25
Phoenix 24
Vienna 23
Rio de Janeiro 22
The Dalles 22
Fairfield 21
Manchester 21
Poplar 21
Turin 21
Norwalk 19
Tashkent 19
Woodbridge 19
Dhaka 18
Falkenstein 18
Quito 18
Falls Church 17
Baghdad 16
Brno 16
Naples 16
Timisoara 16
Florence 15
Washington 15
Ankara 14
Biên Hòa 14
Columbus 14
Düsseldorf 14
Hyderabad 14
Redwood City 14
Amman 13
Belo Horizonte 13
Jakarta 13
Lahore 13
Totale 12.411
Nome #
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 348
Anemia in patients with Covid-19: pathogenesis and clinical significance 290
A Clinicopathologic Comparison Between Early-Onset and Late-Onset Small Bowel Adenocarcinoma: A Multicenter International Study 247
A consensus for the development of a vector model to assess clinical complexity 180
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 176
Detection of Active Epstein-Barr Virus Infection in Duodenal Mucosa of Patients With Refractory Celiac Disease 165
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 162
A mid-term follow-up with a lung ultrasonographic score correlates with the severity of COVID-19 acute phase 161
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 160
Distinguishing Features of Autoimmune Gastritis Depending on Previous Helicobacter pylori Infection or Positivity to Anti-Parietal Cell Antibodies: Results From the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 158
Abnormal post-prandial glucagon-like peptide release in patients with Crohn's disease 154
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 153
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 153
Oxyntic gland intraepithelial T lymphocytes as progression marker of potential autoimmune gastritis 153
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 152
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium 150
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 150
A laboratory score in the diagnosis of autoimmune atrophic gastritis: A prospective study 148
Long-Term Natural History of Autoimmune Gastritis: Results From a Prospective Monocentric Series 144
Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19 142
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 139
Acute kidney injury caused by COVID-19 in a patient with Crohn's disease treated with adalimumab 137
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 134
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 133
Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas 133
Pinworm Infection Misdiagnosed With Primary Eosinophilic Colitis. A Case Series 127
Small bowel adenocarcinomas featuring special at-rich sequence-binding protein 2 (Satb2) expression and a colorectal cancer-like immunophenotype: A potential diagnostic pitfall 127
Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy 125
Association between defective spleen function and primary eosinophilic gastrointestinal disorders 124
Diagnostic delay in adult coeliac disease: An Italian multicentre study 123
Multidimensional Prognostic Index Predicts Clinical Outcome and Mortality in Hospitalised Older Patients with Diverticular Disease 123
Infertility and recurrent miscarriage in a patient with autoimmune atrophic gastritis 122
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 122
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 122
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 121
Acquired von Willebrand syndrome in inflammatory bowel disease 121
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 121
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population 121
Defective spleen function in autoimmune gastrointestinal disorders 119
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 117
Allergic manifestations in autoimmune gastrointestinal disorders 115
Common features of patients with autoimmune atrophic gastritis. 114
Clinical and Histopathological Features of an Italian Monocentric Series of Primary Small Bowel T-Cell Lymphomas 114
Aging underlies heterogeneity between comorbidity and multimorbidity frameworks 113
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 113
Poorly Cohesive Carcinoma of the Nonampullary Small Intestine: A Distinct Histologic Subtype with Prognostic Significance 112
Clinical and atopic features of patients with primary eosinophilic colitis: an Italian multicentre study 110
Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 110
Increase in chromogranin A- and serotonin-positive cells in pouch mucosa of patients with ulcerative colitis undergoing proctocolectomy 109
Determinants of diagnostic delay in autoimmune atrophic gastritis 109
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 107
The time course of diagnostic delay in inflammatory bowel disease over the last sixty years: An Italian multicentre study 106
Autoimmune diseases associated with common variable immune deficiency 106
Diagnostic Delay of Celiac Disease in Childhood 105
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 104
Cell Blood Count Alterations and Patterns of Anaemia in Autoimmune Atrophic Gastritis at Diagnosis: A Multicentre Study 104
Histologic heterogeneity and syndromic associations of non-ampullary duodenal polyps and superficial mucosal lesions 104
Impact of COVID-19 in immunosuppressive drug-naïve autoimmune disorders: Autoimmune gastritis, celiac disease, type 1 diabetes, and autoimmune thyroid disease 104
Increase of Deep Intraepithelial Lymphocytes in the Oxyntic Mucosa of Patients With Potential and Overt Autoimmune Gastritis 103
Diagnostic Delay of Pulmonary Embolism in COVID-19 Patients 103
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy 103
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 102
Controlling Gut Inflammation by Restoring Anti-Inflammatory Pathways in Inflammatory Bowel Disease 102
QTc Interval and Mortality in a Population of SARS-2-CoV Infected Patients 102
Incidence and risk factors for preneoplastic and neoplastic lesions of the colon and rectum in patients under 50 referred for colonoscopy 102
Diagnostic delay in symptomatic uncomplicated diverticular disease: an Italian tertiary referral centre study 101
Validation of the Italian translation of the perceived stigma scale and resilience assessment in inflammatory bowel disease patients 101
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 101
Bringing complexity into clinical practice: An internistic approach 100
Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaign 100
Natural history of autoimmune atrophic gastritis: a prospective, single centre, long-term experience 100
Clinical complexity and hospital admissions in the December holiday period 100
LINE-1 hypomethylation characterizes the inflammatory response in coeliac disease associated-intestinal mucosa and small bowel adenocarcinomas 99
Vaccination coverage and mortality after splenectomy: results from an Italian single-centre study 98
Separation of low versus high grade Crohn's disease-associated small bowel carcinomas is improved by invasive front prognostic marker analysis 98
Corrigendum: Diagnostic Delay of Pulmonary Embolism in COVID-19 Patients 98
Preventing Infections by Encapsulated Bacteria Through Vaccine Prophylaxis in Inflammatory Bowel Disease 97
Resilience is associated with frailty and older age in hospitalised patients 96
Evaluation of diagnostic time in pediatric patients with eosinophilic gastrointestinal disorders according to their clinical features 96
Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study 96
Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases 96
Clinical and gastro-duodenal histopathological features of enteropathy due to angiotensin II receptor blockers 96
Administrative data for exploring multimorbidity in hospitalised patients 95
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD) 94
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 94
Reproducibility in the Assessment of the Components of a Clinical Complexity Index 94
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 94
Global Meta-Analysis on the Association between Behcet Syndrome and Polymorphisms from the HLA Class I (A, B, and C) and Class II (DRB1, DQB1, and DPB1) Genes 94
Disruption of epithelial barrier integrity via altered GILZ/c-Rel/RACK1 signaling in inflammatory bowel disease (IBD) 93
Medullary carcinomas of the nonampullary small intestine: association with coeliac disease, mismatch repair deficiency, PD‐L1 expression, and favourable prognosis 93
Reflux symptoms in professional opera soloists 92
Impaired Quality of Life in Patients with Autoimmune Atrophic Gastritis 91
Safety and durability of PEG-J: a single-centre experience 91
COVID-19-related symptom clustering in a primary care vs internal medicine setting 91
Clinical outcomes of diverticular disease in young adults: results from a tertiary referral center 90
Autoimmune gastritis 90
Serum markers of refractoriness and enteropathy-associated t-cell lymphoma in coeliac disease 90
Validation of the Red Flags Index for Early Diagnosis of Crohn's Disease: A Prospective Observational IG-IBD Study Among General Practitioners 89
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study 88
Seronegative autoimmune diseases: A challenging diagnosis 88
Totale 12.057
Categoria #
all - tutte 90.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022652 0 3 27 6 12 16 11 77 43 32 72 353
2022/20232.320 206 177 20 134 147 212 43 123 1.131 29 73 25
2023/20241.313 116 195 38 70 163 305 122 86 15 74 60 69
2024/20254.211 92 212 110 190 132 319 344 257 1.001 225 458 871
2025/20269.353 616 565 1.063 1.093 1.035 388 1.808 487 868 582 439 409
2026/2027368 363 5 0 0 0 0 0 0 0 0 0 0
Totale 19.554